Skip to main content
. 2019 Feb 10;9(5):1021–1034. doi: 10.1016/j.apsb.2019.02.001

Figure 2.

Fig. 2

MCC1019 inhibit downstream effector proteins of PLK1. (A) Western blot analysis of BUBR1, p-AKT, p-FOXO1 and HIF-1α after treatment with different concentrations of MCC1019 for 24 h. Data represent relative expression intensity to β-actin, Error bars are ± SD of three independent experiments. (B) Diagram showing molecular effects of PLK1 inhibition on AKT signaling pathway that appeared in the study.